JEFFREY WEISS
- Type
- Physician · Allopathic & Osteopathic Physicians / Allergy & Immunology
- Where
- Riverdale, NJ
- NPI
- 1366625162
- Received
- $532,426 in 1,344 records, 2019 to 2025; ownership interests with $2,510 invested
- As principal investigator
- $302,716 of research payments to others in 53 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 337 | $137,678 |
| 2025 | Ownership or investment interest | 1 | $1,255 |
| 2024 | General payment | 318 | $144,104 |
| 2024 | Ownership or investment interest | 1 | $1,255 |
| 2023 | General payment | 275 | $117,442 |
| 2022 | General payment | 241 | $72,439 |
| 2021 | General payment | 129 | $37,036 |
| 2020 | General payment | 15 | $9,970 |
| 2019 | General payment | 27 | $13,754 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 218 | $462,078 |
| Food and Beverage | 896 | $27,672 |
| Travel and Lodging | 175 | $22,794 |
| Honoraria | 3 | $10,500 |
| Consulting Fee | 21 | $9,006 |
| Ownership or investment interest | 2 | $2,510 |
| Education | 29 | $374 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-23 | AstraZeneca Pharmaceuticals LP | $19 | Food and Beverage | In-kind items and services | FASENRA Biological, Respiratory | 2025 | |
| 2025-12-19 | AstraZeneca Pharmaceuticals LP | $1,770 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-12-18 | Invivyd Inc | $17 | Food and Beverage | In-kind items and services | PEMGARDA Biological, INFECTIOUS DISEASE | 2025 | |
| 2025-12-17 | AstraZeneca Pharmaceuticals LP | $2,325 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-12-17 | AstraZeneca Pharmaceuticals LP | $930 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-12-17 | GENZYME CORPORATION | $15 | Food and Beverage | In-kind items and services | AYVAKIT Biological, Gastroenterology | 2025 | |
| 2025-12-17 | AstraZeneca Pharmaceuticals LP | $14 | Travel and Lodging | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-12-16 | AstraZeneca Pharmaceuticals LP | $590 | Consulting Fee | Cash or cash equivalent | FASENRA Biological, Respiratory | 2025 | |
| 2025-12-16 | Galderma Laboratories, L.P. | $94 | Food and Beverage | In-kind items and services | NEMLUVIO Drug, DERMATITIS | 2025 | |
| 2025-12-16 | GlaxoSmithKline, LLC. | $12 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2025 | |
| 2025-12-12 | Galderma Laboratories, L.P. | $15 | Food and Beverage | In-kind items and services | NEMLUVIO Drug, DERMATITIS | 2025 | |
| 2025-12-11 | Novartis Pharmaceuticals Corporation | $20 | Food and Beverage | In-kind items and services | Rhapsido Drug, Immunology | 2025 | |
| 2025-12-09 | AstraZeneca Pharmaceuticals LP | $3,540 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-12-09 | AstraZeneca Pharmaceuticals LP | $1,395 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-12-08 | AstraZeneca Pharmaceuticals LP | $40 | Travel and Lodging | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-12-08 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-12-05 | GENZYME CORPORATION | $15 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-12-05 | GlaxoSmithKline, LLC. | $12 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-12-03 | Takeda Pharmaceuticals U.S.A., Inc. | $1,127 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | HYQVIA Biological, IMMUNOLOGY | 2025 | |
| 2025-12-03 | Takeda Pharmaceuticals U.S.A., Inc. | $180 | Travel and Lodging | In-kind items and services | HYQVIA Biological, IMMUNOLOGY | 2025 | |
| 2025-12-03 | Takeda Pharmaceuticals U.S.A., Inc. | $164 | Travel and Lodging | In-kind items and services | HYQVIA Biological, IMMUNOLOGY | 2025 | |
| 2025-12-03 | Takeda Pharmaceuticals U.S.A., Inc. | $29 | Travel and Lodging | In-kind items and services | HYQVIA Biological, IMMUNOLOGY | 2025 | |
| 2025-12-03 | Takeda Pharmaceuticals U.S.A., Inc. | $19 | Food and Beverage | In-kind items and services | HYQVIA Biological, IMMUNOLOGY | 2025 | |
| 2025-12-03 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-12-03 | Takeda Pharmaceuticals U.S.A., Inc. | $11 | Travel and Lodging | In-kind items and services | HYQVIA Biological, IMMUNOLOGY | 2025 | |
| 2025-12-01 | Novartis Pharmaceuticals Corporation | $18 | Food and Beverage | In-kind items and services | Rhapsido Drug, Immunology | 2025 | |
| 2025-11-26 | AstraZeneca Pharmaceuticals LP | $2,360 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FASENRA Biological, Respiratory | 2025 | |
| 2025-11-26 | Azurity Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | ALVESCO Drug, ANTI-INFLAMMATORY | 2025 | |
| 2025-11-25 | Takeda Pharmaceuticals U.S.A., Inc. | $5,186 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | HYQVIA Biological, IMMUNOLOGY | 2025 | |
| 2025-11-25 | GENZYME CORPORATION | $17 | Food and Beverage | In-kind items and services | AYVAKIT Biological, Gastroenterology | 2025 | |
| 2025-11-23 | GlaxoSmithKline, LLC. | $18 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-11-20 | AstraZeneca Pharmaceuticals LP | $124 | Food and Beverage | In-kind items and services | FASENRA Biological, Respiratory | 2025 | |
| 2025-11-20 | AstraZeneca Pharmaceuticals LP | $15 | Travel and Lodging | In-kind items and services | FASENRA Biological, Respiratory | 2025 | |
| 2025-11-19 | LEO Pharma Inc. | $18 | Food and Beverage | In-kind items and services | ANZUPGO Drug, DERMATOLOGY | 2025 | |
| 2025-11-19 | Amgen Inc. | $16 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Inflammation | 2025 | |
| 2025-11-18 | ADMA BioManufacturing LLC | $21 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-11-17 | CSL Behring | $20 | Food and Beverage | In-kind items and services | Andembry Biological, Hematology | 2025 | |
| 2025-11-17 | GlaxoSmithKline, LLC. | $15 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-11-15 | GlaxoSmithKline, LLC. | $19 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2025 | |
| 2025-11-14 | Galderma Laboratories, L.P. | $16 | Food and Beverage | In-kind items and services | NEMLUVIO Drug, DERMATITIS | 2025 | |
| 2025-11-14 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-11-13 | Grifols USA, LLC | $115 | Food and Beverage | In-kind items and services | Xembify Biological, Immunology and Neurology | 2025 | |
| 2025-11-13 | AstraZeneca Pharmaceuticals LP | $13 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-11-12 | AstraZeneca Pharmaceuticals LP | $250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-11-12 | AstraZeneca Pharmaceuticals LP | $125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-11-08 | AstraZeneca Pharmaceuticals LP | $70 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-11-08 | Incyte Corporation | $58 | Food and Beverage | Cash or cash equivalent | Opzelura Drug, Dermatology | 2025 | |
| 2025-11-06 | GlaxoSmithKline, LLC. | $15 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-11-05 | AstraZeneca Pharmaceuticals LP | $33 | Travel and Lodging | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-11-05 | AstraZeneca Pharmaceuticals LP | $18 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-11-04 | PFIZER INC. | $13 | Food and Beverage | In-kind items and services | CIBINQO Drug, Inflammation & Immunology | 2025 | |
| 2025-11-03 | AstraZeneca Pharmaceuticals LP | $2,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-11-03 | Galderma Laboratories, L.P. | $14 | Food and Beverage | In-kind items and services | NEMLUVIO Drug, DERMATITIS | 2025 | |
| 2025-10-30 | Novartis Pharmaceuticals Corporation | $21 | Food and Beverage | In-kind items and services | Rhapsido Drug, Immunology | 2025 | |
| 2025-10-28 | ADMA BioManufacturing LLC | $4,000 | Honoraria | Cash or cash equivalent | 2025 | ||
| 2025-10-28 | ADMA BioManufacturing LLC | $120 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-10-28 | ADMA BioManufacturing LLC | $37 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-10-27 | AstraZeneca Pharmaceuticals LP | $1,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FASENRA Biological, Respiratory | 2025 | |
| 2025-10-26 | PFIZER INC. | $16 | Food and Beverage | In-kind items and services | CIBINQO Drug, Inflammation & Immunology | 2025 | |
| 2025-10-23 | Takeda Pharmaceuticals U.S.A., Inc. | $123 | Food and Beverage | In-kind items and services | HYQVIA Biological, IMMUNOLOGY | 2025 | |
| 2025-10-22 | Consortium of Independent Immunology Clinics, LLC | $750 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-10-22 | Lilly USA, LLC | $17 | Food and Beverage | In-kind items and services | EBGLYSS Drug, Immunology | 2025 | |
| 2025-10-21 | AstraZeneca Pharmaceuticals LP | $1,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-10-21 | AstraZeneca Pharmaceuticals LP | $104 | Food and Beverage | In-kind items and services | FASENRA Biological, Respiratory | 2025 | |
| 2025-10-21 | Invivyd Inc | $19 | Food and Beverage | In-kind items and services | PEMGARDA Biological, INFECTIOUS DISEASE | 2025 | |
| 2025-10-21 | AstraZeneca Pharmaceuticals LP | $10 | Travel and Lodging | In-kind items and services | FASENRA Biological, Respiratory | 2025 | |
| 2025-10-16 | AstraZeneca Pharmaceuticals LP | $125 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-10-16 | AstraZeneca Pharmaceuticals LP | $93 | Travel and Lodging | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-10-16 | Organon Llc | $17 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-16 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-10-15 | Regeneron Healthcare Solutions, Inc. | $13 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-10-14 | Genentech USA, Inc. | $14 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2025 | |
| 2025-10-13 | Galderma Laboratories, L.P. | $17 | Food and Beverage | In-kind items and services | NEMLUVIO Drug, DERMATITIS | 2025 | |
| 2025-10-13 | BioCryst US Sales Co., LLC | $17 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-10 | AstraZeneca Pharmaceuticals LP | $2,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FASENRA Biological, Respiratory | 2025 | |
| 2025-10-10 | GENZYME CORPORATION | $18 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-10-10 | Invivyd Inc | $13 | Food and Beverage | In-kind items and services | PEMGARDA Biological, INFECTIOUS DISEASE | 2025 | |
| 2025-10-09 | AstraZeneca Pharmaceuticals LP | $128 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-10-09 | ADMA BioManufacturing LLC | $23 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-10-08 | Pharming Healthcare, Inc. | $19 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-10-07 | AstraZeneca Pharmaceuticals LP | $125 | Food and Beverage | In-kind items and services | FASENRA Biological, Respiratory | 2025 | |
| 2025-10-07 | AstraZeneca Pharmaceuticals LP | $58 | Travel and Lodging | In-kind items and services | FASENRA Biological, Respiratory | 2025 | |
| 2025-10-07 | Novartis Pharmaceuticals Corporation | $17 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-06 | AstraZeneca Pharmaceuticals LP | $1,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-10-06 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | FASENRA Biological, Respiratory | 2025 | |
| 2025-10-03 | Invivyd Inc | $19 | Food and Beverage | In-kind items and services | PEMGARDA Biological, INFECTIOUS DISEASE | 2025 | |
| 2025-10-02 | GlaxoSmithKline, LLC. | $2,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-10-02 | Azurity Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | ALVESCO Drug, ANTI-INFLAMMATORY | 2025 | |
| 2025-09-29 | GlaxoSmithKline, LLC. | $70 | Travel and Lodging | Cash or cash equivalent | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-09-29 | GlaxoSmithKline, LLC. | $41 | Travel and Lodging | Cash or cash equivalent | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-09-29 | CSL Behring | $21 | Food and Beverage | In-kind items and services | Andembry Biological, Hematology | 2025 | |
| 2025-09-26 | ADMA BioManufacturing LLC | $4,000 | Honoraria | Cash or cash equivalent | 2025 | ||
| 2025-09-26 | ADMA BioManufacturing LLC | $905 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-09-26 | ADMA BioManufacturing LLC | $310 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-09-26 | ADMA BioManufacturing LLC | $180 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-09-25 | GlaxoSmithKline, LLC. | $18 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-09-24 | Novartis Pharmaceuticals Corporation | $15 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-23 | Greer Laboratories, Inc. | $29 | Food and Beverage | In-kind items and services | ORALAIR Biological, Allergy Treatment | 2025 | |
| 2025-09-19 | GlaxoSmithKline, LLC. | $18 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2025 | |
| 2025-09-18 | AstraZeneca Pharmaceuticals LP | $135 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-09-18 | Ionis Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | DAWNZERA Drug, PULMONOLOGY & IMMUNOLOGY | 2025 | |
| 2025-09-18 | AstraZeneca Pharmaceuticals LP | $15 | Travel and Lodging | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-09-18 | ADMA BioManufacturing LLC | $6 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-09-15 | GlaxoSmithKline, LLC. | $2,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-09-15 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-09-12 | LEO Pharma Inc. | $17 | Food and Beverage | In-kind items and services | ANZUPGO Drug, DERMATOLOGY | 2025 | |
| 2025-09-12 | Organon Llc | $15 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-11 | GlaxoSmithKline, LLC. | $125 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-09-11 | AstraZeneca Pharmaceuticals LP | $18 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-09-10 | GENZYME CORPORATION | $20 | Food and Beverage | In-kind items and services | AYVAKIT Biological, Gastroenterology | 2025 | |
| 2025-09-09 | ADMA BioManufacturing LLC | $26 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-09-09 | GlaxoSmithKline, LLC. | $7 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-09-08 | GlaxoSmithKline, LLC. | $14 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-09-02 | Takeda Pharmaceuticals U.S.A., Inc. | $3,833 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CUVITRU Biological, IMMUNOLOGY | 2025 | |
| 2025-09-02 | Takeda Pharmaceuticals U.S.A., Inc. | $131 | Travel and Lodging | In-kind items and services | CUVITRU Biological, IMMUNOLOGY | 2025 | |
| 2025-09-02 | Takeda Pharmaceuticals U.S.A., Inc. | $1 | Travel and Lodging | In-kind items and services | CUVITRU Biological, IMMUNOLOGY | 2025 | |
| 2025-08-27 | Grifols USA, LLC | $56 | Food and Beverage | In-kind items and services | Xembify Biological, Immunology and Neurology | 2025 | |
| 2025-08-25 | GlaxoSmithKline, LLC. | $1 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2025 | |
| 2025-08-22 | AstraZeneca Pharmaceuticals LP | $2,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-08-20 | AstraZeneca Pharmaceuticals LP | $105 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-08-20 | AstraZeneca Pharmaceuticals LP | $43 | Travel and Lodging | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-08-20 | Amgen Inc. | $34 | Education | In-kind items and services | 2025 | ||
| 2025-08-20 | Novartis Pharmaceuticals Corporation | $19 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-08-19 | GC Biopharma USA, Inc. | $14 | Food and Beverage | In-kind items and services | ALYGLO Drug, IMMUNOLOGY | 2025 | |
| 2025-08-18 | ADMA BioManufacturing LLC | $6 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-08-14 | GlaxoSmithKline, LLC. | $2,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-08-14 | GlaxoSmithKline, LLC. | $64 | Travel and Lodging | Cash or cash equivalent | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-08-13 | Takeda Pharmaceuticals U.S.A., Inc. | $124 | Food and Beverage | In-kind items and services | CUVITRU Biological, IMMUNOLOGY | 2025 | |
| 2025-08-13 | AstraZeneca Pharmaceuticals LP | $17 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-08-12 | AstraZeneca Pharmaceuticals LP | $250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-08-12 | Galderma Laboratories, L.P. | $12 | Food and Beverage | In-kind items and services | NEMLUVIO Drug, DERMATITIS | 2025 | |
| 2025-08-08 | GlaxoSmithKline, LLC. | $2,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-08-07 | Amgen Inc. | $17 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Inflammation | 2025 | |
| 2025-08-06 | Cycle Pharmaceuticals Inc | $28 | Food and Beverage | Cash or cash equivalent | Sajazir Drug, Immunology | 2025 | |
| 2025-08-05 | AstraZeneca Pharmaceuticals LP | $250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-08-05 | BioCryst US Sales Co., LLC | $16 | Food and Beverage | In-kind items and services | ORLADEYO Drug, Immunology | 2025 | |
| 2025-08-05 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-08-04 | GlaxoSmithKline, LLC. | $13 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2025 | |
| 2025-08-01 | AstraZeneca Pharmaceuticals LP | $1,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-07-31 | Lilly USA, LLC | $18 | Food and Beverage | In-kind items and services | EBGLYSS Drug, Immunology | 2025 | |
| 2025-07-31 | GlaxoSmithKline, LLC. | $15 | Travel and Lodging | Cash or cash equivalent | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-07-30 | Novartis Pharmaceuticals Corporation | $23 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-07-30 | Novartis Pharmaceuticals Corporation | $19 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-07-28 | AstraZeneca Pharmaceuticals LP | $2,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-07-27 | BioCryst US Sales Co., LLC | $14 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-07-25 | AstraZeneca Pharmaceuticals LP | $1,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-07-24 | AstraZeneca Pharmaceuticals LP | $113 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-07-24 | AstraZeneca Pharmaceuticals LP | $15 | Travel and Lodging | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-07-23 | AstraZeneca Pharmaceuticals LP | $1,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-07-23 | Grifols USA, LLC | $24 | Food and Beverage | In-kind items and services | Xembify Biological, Immunology and Neurology | 2025 | |
| 2025-07-23 | GlaxoSmithKline, LLC. | $16 | Travel and Lodging | Cash or cash equivalent | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-07-23 | GlaxoSmithKline, LLC. | $16 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-07-22 | AstraZeneca Pharmaceuticals LP | $125 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-07-22 | AstraZeneca Pharmaceuticals LP | $15 | Travel and Lodging | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-07-21 | GlaxoSmithKline, LLC. | $2,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-07-17 | AstraZeneca Pharmaceuticals LP | $87 | Travel and Lodging | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-07-17 | AstraZeneca Pharmaceuticals LP | $64 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-07-17 | Amgen Inc. | $14 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Inflammation | 2025 | |
| 2025-07-16 | Genentech USA, Inc. | $17 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2025 | |
| 2025-07-15 | Galderma Laboratories, L.P. | $17 | Food and Beverage | In-kind items and services | NEMLUVIO Drug, DERMATITIS | 2025 | |
| 2025-07-14 | GlaxoSmithKline, LLC. | $105 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-07-14 | Regeneron Healthcare Solutions, Inc. | $18 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-07-10 | AstraZeneca Pharmaceuticals LP | $124 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-07-10 | Novartis Pharmaceuticals Corporation | $20 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-07-10 | Lilly USA, LLC | $17 | Food and Beverage | In-kind items and services | EBGLYSS Drug, Immunology | 2025 | |
| 2025-07-10 | GlaxoSmithKline, LLC. | $10 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-07-07 | GlaxoSmithKline, LLC. | $17 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2025 | |
| 2025-07-01 | Galderma Laboratories, L.P. | $18 | Food and Beverage | In-kind items and services | NEMLUVIO Drug, DERMATITIS | 2025 | |
| 2025-06-30 | GlaxoSmithKline, LLC. | $11 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-06-26 | Pharming Healthcare, Inc. | $18 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-06-25 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-06-24 | Takeda Pharmaceuticals U.S.A., Inc. | $16 | Food and Beverage | In-kind items and services | HYQVIA Biological, IMMUNOLOGY | 2025 | |
| 2025-06-19 | Ionis Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-06-18 | AstraZeneca Pharmaceuticals LP | $2,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-06-17 | GlaxoSmithKline, LLC. | $3 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2025 | |
| 2025-06-13 | Grifols USA, LLC | $28 | Food and Beverage | In-kind items and services | Xembify Biological, Immunology and Neurology | 2025 | |
| 2025-06-12 | GlaxoSmithKline, LLC. | $10 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-06-11 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-06-10 | GlaxoSmithKline, LLC. | $3,900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-06-10 | AstraZeneca Pharmaceuticals LP | $118 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-06-10 | AstraZeneca Pharmaceuticals LP | $68 | Travel and Lodging | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-06-10 | PFIZER INC. | $16 | Food and Beverage | In-kind items and services | CIBINQO Drug, Inflammation & Immunology | 2025 | |
| 2025-06-09 | AstraZeneca Pharmaceuticals LP | $13 | Food and Beverage | In-kind items and services | FASENRA Biological, Respiratory | 2025 | |
| 2025-06-06 | GlaxoSmithKline, LLC. | $147 | Travel and Lodging | Cash or cash equivalent | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-06-06 | Invivyd Inc | $15 | Food and Beverage | In-kind items and services | PEMGARDA Biological, INFECTIOUS DISEASE | 2025 | |
| 2025-06-05 | Amgen Inc. | $17 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Inflammation | 2025 | |
| 2025-06-04 | GlaxoSmithKline, LLC. | $2,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-06-04 | Genentech USA, Inc. | $17 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2025 | |
| 2025-06-03 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | FASENRA Biological, Respiratory | 2025 | |
| 2025-06-03 | Genentech USA, Inc. | $14 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2025 | |
| 2025-06-02 | GlaxoSmithKline, LLC. | $14 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-05-28 | GENZYME CORPORATION | $22 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-05-27 | Takeda Pharmaceuticals U.S.A., Inc. | $1,127 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | HYQVIA Biological, IMMUNOLOGY | 2025 | |
| 2025-05-27 | GlaxoSmithKline, LLC. | $13 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2025 | |
| 2025-05-22 | AstraZeneca Pharmaceuticals LP | $2,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FASENRA Biological, Respiratory | 2025 | |
| 2025-05-22 | AstraZeneca Pharmaceuticals LP | $18 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-05-21 | Lilly USA, LLC | $18 | Food and Beverage | In-kind items and services | EBGLYSS Drug, Immunology | 2025 | |
| 2025-05-21 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2025 | |
| 2025-05-20 | AstraZeneca Pharmaceuticals LP | $121 | Food and Beverage | In-kind items and services | FASENRA Biological, Respiratory | 2025 | |
| 2025-05-20 | AstraZeneca Pharmaceuticals LP | $47 | Travel and Lodging | In-kind items and services | FASENRA Biological, Respiratory | 2025 |
The latest 200 records of 1,344.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2025-12-25 | PFIZER INC. | EMPIRICAN PRN INC DBA CIRCUIT CLINICAL | $100 | A PHASE 2 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PARALLELGROUP DOSERANGING STUDY TO INVESTIGATE THE EFFICACY AND SAFET | 2025 |
| 2025-10-22 | AstraZeneca UK Limited | CIRCUIT CLINICAL | $3,791 | a twelfeweek randomized doubleblind phase four study evaluating the effect of airsupra compared to albuterol administere | 2025 |
| 2025-10-08 | Novartis Pharmaceuticals Corporation | IMPACT MEDICAL | $216 | A US Phase 3b, Multi-center, Randomized, Double-blind, Double-Dummy Study to Evaluate Efficacy of Remibrutinib Compared | 2025 |
| 2025-09-24 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $1,500 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2025 |
| 2025-09-12 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $500 | A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL | 2025 |
| 2025-09-03 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $500 | A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL | 2025 |
| 2025-08-02 | PFIZER INC. | EMPIRICAN PRN INC DBA CIRCUIT CLINICAL | $9,000 | A PHASE 2 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PARALLELGROUP DOSERANGING STUDY TO INVESTIGATE THE EFFICACY AND SAFET | 2025 |
| 2025-08-01 | Novartis Pharmaceuticals Corporation | IMPACT MEDICAL | $17,320 | A US Phase 3b, Multi-center, Randomized, Double-blind, Double-Dummy Study to Evaluate Efficacy of Remibrutinib Compared | 2025 |
| 2025-06-10 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $500 | A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL | 2025 |
| 2025-06-10 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $500 | A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL | 2025 |
| 2025-06-06 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $1,562 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2025 |
| 2025-06-06 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $5,649 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2025 |
| 2025-06-05 | PFIZER INC. | EMPIRICAN PRN INC DBA CIRCUIT CLINICAL | $15,042 | A PHASE 2 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PARALLELGROUP DOSERANGING STUDY TO INVESTIGATE THE EFFICACY AND SAFET | 2025 |
| 2025-06-05 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $500 | A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL | 2025 |
| 2025-05-26 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $3,844 | A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL | 2025 |
| 2025-05-21 | AstraZeneca UK Limited | CIRCUIT CLINICAL | $20,050 | a randomized,double blind,multicenter,parallel group,phase IIIb 52 week study evaluating the efficacy and safety of PT0 | 2025 |
| 2025-04-28 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $235 | A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL | 2025 |
| 2025-04-28 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $235 | A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL | 2025 |
| 2025-04-09 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $5,487 | A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL | 2025 |
| 2025-04-08 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $1,000 | A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL | 2025 |
| 2025-03-21 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $500 | A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL | 2025 |
| 2025-03-21 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $1,287 | A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL | 2025 |
| 2025-03-07 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $4,029 | A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL | 2025 |
| 2025-02-24 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $16,731 | A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL | 2025 |
| 2025-02-24 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $500 | A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL | 2025 |
| 2025-02-05 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $1,500 | A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL | 2025 |
| 2025-02-05 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $12,750 | A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL | 2025 |
| 2025-02-05 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $2,571 | A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL | 2025 |
| 2025-01-29 | AstraZeneca Pharmaceuticals LP | CIRCUIT CLINICAL | $21,686 | Levante A Phase 2b Randomised Double Blind Placebo Controlled Dose Range Finding Study to Assess Efficacy and Safety of | 2025 |
| 2025-01-13 | AstraZeneca Pharmaceuticals LP | CIRCUIT CLINICAL | $52,116 | a twelfeweek randomized doubleblind phase four study evaluating the effect of airsupra compared to albuterol administere | 2025 |
| 2025-01-09 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $7,317 | A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL | 2025 |
| 2024-12-08 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $17,201 | A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL | 2024 |
| 2024-12-08 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $1,830 | A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL | 2024 |
| 2024-12-08 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $7,948 | A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL | 2024 |
| 2024-09-18 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $3,844 | A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL | 2024 |
| 2024-09-18 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $7,688 | A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTI-CENTER STUDY TO EVAL | 2024 |
| 2024-06-14 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $766 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2024 |
| 2024-05-06 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $2,236 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2024 |
| 2024-04-15 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $1,133 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2024 |
| 2024-03-13 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $765 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2024 |
| 2024-02-02 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $1,462 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2024 |
| 2024-01-12 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $765 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2024 |
| 2024-01-10 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $1,000 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2024 |
| 2023-12-06 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $978 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2023 |
| 2023-11-10 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $2,848 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2023 |
| 2023-10-10 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $893 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2023 |
| 2023-09-06 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $1,334 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2023 |
| 2023-08-09 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $850 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2023 |
| 2023-08-03 | Amgen Inc. | WEISS MEDICAL | $787 | P3 AD Monotherapy Induction | 2023 |
| 2023-07-12 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $8,251 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2023 |
| 2023-05-05 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $2,500 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2023 |
| 2023-05-05 | GlaxoSmithKline, LLC. | EMPIRICAN PRN INC | $13,855 | A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL | 2023 |
| 2023-04-11 | AstraZeneca Pharmaceuticals LP | CIRCUIT CLINICAL | $15,250 | A Multicenter Open label Phase 3B Efficacy and Safety Study of Tezepelumab 210 mg Administered Subcutaneously to Reduce | 2023 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Riverdale, NJ, county Morris County, NJ, state New Jersey; placed by its city name.
| Measure | Place (city or town) Riverdale, NJ | County Morris County, NJ | State New Jersey |
|---|---|---|---|
| Population B01003 | 4,112 | 514,528 | 9,343,809 |
| Population, 2020 census P1 | 4,107 | 509,285 | 9,288,994 |
| Median age B01002 | 50.2 | 42.6 | 40.1 |
| Under 18 B01001 | 16.3% | 20.6% | 21.8% |
| 65 and over B01001 | 22.7% | 18.2% | 17.2% |
| Households B11001 | 1,873 | 193,245 | 3,507,701 |
| Foreign born B05002 | 14.6% | 19.8% | 23.9% |
| Median household income B19013 | $102,950 | $137,326 | $103,556 |
| Median family income B19113 | $137,222 | $169,844 | $127,025 |
| Per capita income B19301 | $58,340 | $71,044 | $54,253 |
| Poverty rate B17001 | 7.7% | 4.9% | 9.7% |
| Unemployment rate B23025 | 0.8% | 5.2% | 6.3% |
| Civilian labor force B23025 | 2,359 | 288,525 | 5,003,179 |
| Mean commute (minutes) B08013 | 27.5 | 29.8 | 30.5 |
| Bachelor's degree or higher B15003 | 47.0% | 57.8% | 43.6% |
| Housing units B25001 | 1,919 | 199,506 | 3,791,354 |
| Owner-occupied B25003 | 70.6% | 74.3% | 63.8% |
| Renters B25003 | 29.4% | 25.7% | 36.2% |
| Median home value B25077 | $395,900 | $582,500 | $454,400 |
| Median gross rent B25064 | $2,424 | $1,904 | $1,720 |
| White, not Hispanic B03002 | 81.1% | 65.8% | 50.9% |
| Black B03002 | 0.9% | 3.0% | 12.2% |
| Hispanic or Latino B03002 | 10.4% | 16.0% | 22.5% |
| Asian B03002 | 3.3% | 10.7% | 10.0% |
| American Indian and Alaska Native B03002 | 0.0% | 0.0% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Riverdale, NJ.
Comments